Key result
Two-year treatment with atorvastatin (20 mg/day) significantly reduced aortic stiffness by 14% (p=0.019) in hypercholesterolaemic patients.
Why the study?
Does atorvastatin 20 mg/day improve aortic stiffness in hypercholesterolaemic patients?
Observational (n=36)
Does atorvastatin 20 mg/day improve aortic stiffness in hypercholesterolaemic patients?
p-value: p=0.019
Long-term treatment with atorvastatin 20 mg/day significantly reduced aortic stiffness by 14% over 2 years in hypercholesterolaemic patients.
No takes yet. Share an insight, caveat, or question.
Supports vascular benefits in hypercholesterolemia; leaves open outcome impact without randomized confirmation.
Kontopoulos et al. (2003) conducted an observational in Hypercholesterolaemia (n=36). Atorvastatin was evaluated on Aortic stiffness (p=0.019). Two-year treatment with atorvastatin (20 mg/day) significantly reduced aortic stiffness by 14% (p=0.019) in hypercholesterolaemic patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: